EFTA Document EFTA01468514

Subject: $1Y and Biotech From: Tazia Smith < Date: Wed, 23 Apr 2014 11:54:04 -0400 To: 'eevacation@•mail.com Cc: Paul Morris Nav Gupta < Vinit Sahni Vahe Stepanian < Classification: Confidential Jeffrey - Just posting you on your biotech basket - earnings a positive catalyst reversing that downtrend in Gilead. Biogen reported this morning (bottom line miss, top-line beat), stock has come in from pre-market highs of $310, now - $303 (3-day chart below). Just a reminder that your $Y